Your browser doesn't support javascript.
loading
Does Pink October really impact breast cancer screening?
Antonini, Marcelo; Pinheiro, Denise Joffily Pereira da Costa; Salerno, Gisela Rosa Franco; Matos, Ana Beatriz Tavares de Moura Brasil; Ferraro, Odair; Mattar, André; Lopes, Reginaldo Guedes Coelho; Real, Juliana Monte.
Afiliação
  • Antonini M; Hospital do Servido Público Estadual - Francisco Morato Oliveira (HSPE-FMO), São Paulo, Brazil.
  • Pinheiro DJPDC; CEDEP - Instituto de Assistência Médica ao Servidor Público Estadual (IAMSPE), São Paulo, Brazil.
  • Salerno GRF; Hospital do Servido Público Estadual - Francisco Morato Oliveira (HSPE-FMO), São Paulo, Brazil.
  • Matos ABTMB; Physiotherapy department, Universidade Presbiteriana Mackenzie, São Paulo, Brazil.
  • Ferraro O; Hospital do Servido Público Estadual - Francisco Morato Oliveira (HSPE-FMO), São Paulo, Brazil.
  • Mattar A; Hospital do Servido Público Estadual - Francisco Morato Oliveira (HSPE-FMO), São Paulo, Brazil.
  • Lopes RGC; Hospital Pérola Byington, São Paulo, Brazil.
  • Real JM; Hospital do Servido Público Estadual - Francisco Morato Oliveira (HSPE-FMO), São Paulo, Brazil.
Public Health Pract (Oxf) ; 4: 100316, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36570401
Objective: This study aims to evaluate the impact of the Pink October Campaign on the increase in mammographic screening in Brazil. Study design: Ecological observational study, based on retrospective data. Methods: Brazilian national screening database (DATASUS/SISMAMA/Information System on Breast Cancer) was used as a data source and is publicly available for download and analysis. We report screening numbers and outcome rates from January 2017 to December 2021 comparing statistically (ANOVA test, post-Tukey test), age groups, regions of Brazil, and the four quarters of the year. Results: During the study period, the average number of exams performed monthly over the five years was 137,400.117. An increase in the number of mammograms performed in October was identified, as well as in the two following months, respectively 33%, 39%, and 22%, with statistical significance (p = 0.000) in relation to the three quarters of the year. In addition, in the other months, we found values below the monthly average. Statistical difference was not found in the increase in mammograms considering age groups (p = 0.5) and different regions of the country (p = 0.6). Conclusions: This study showed an increase in mammographic screening in the three months following the Pink October Campaign, so we should intensify similar actions throughout the year and not just in October.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Observational_studies / Screening_studies Idioma: En Revista: Public Health Pract (Oxf) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Brasil País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Observational_studies / Screening_studies Idioma: En Revista: Public Health Pract (Oxf) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Brasil País de publicação: Reino Unido